Fabio
5.9 KiB
5.9 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Prescription drug donation program; Bd. of Pharmacy shall convene a work group to evaluate, report. | Board of Pharmacy; prescription drug donation program; work group. Directs the Board of Pharmacy to convene a work group of interested stakeholders to evaluate any challenges and barriers to participation in the prescription drug donation program and ways to increase program participation, education, and outreach. The bill requires the work group to report its findings to the Governor and the Chairmen of the House Committee on Health, Welfare and Institutions and the Senate Committee on Education and Health by December 1, 2022. | us/states/va | Virginia General Assembly | 2022 | SB 14 | Virginia SB 14 (2022) |
|
enacted |
|
5 | 36 | 7 | 2021-12-19 | 2022-04-27 | openstates | ocd-bill/42d8d282-3256-4fda-9a6c-44e774e0a099 | https://lis.virginia.gov/cgi-bin/legp604.exe?221+sum+SB14 | 57111b4f1320a3118c5932b3457134b8707c95afd44717cdd8c91c0ca868a7b7 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 14 (2022) — Prescription drug donation program; Bd. of Pharmacy shall convene a work group to evaluate, report.
Board of Pharmacy; prescription drug donation program; work group. Directs the Board of Pharmacy to convene a work group of interested stakeholders to evaluate any challenges and barriers to participation in the prescription drug donation program and ways to increase program participation, education, and outreach. The bill requires the work group to report its findings to the Governor and the Chairmen of the House Committee on Health, Welfare and Institutions and the Senate Committee on Education and Health by December 1, 2022.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0703 (committee substitute) — source
- Committee substitute printed 22104388D-S1 (committee substitute) — source
- Prefiled and ordered printed; offered 01/12/22 22100296D (committee substitute) — source
- SB14ER (committee substitute) — source
- SB14ER2 (committee substitute) — source
Votes
- VOTE: Adoption (100-Y 0-N) — 99–0 (pass) · lower
- Read third time and passed Senate (40-Y 0-N) — 40–0 (pass) · upper
- Reported from Education and Health with substitute (14-Y 0-N) — 14–0 (pass) · upper
- Senate concurred in Governor's recommendation (40-Y 0-N) — 40–0 (pass) · upper
- VOTE: Block Vote Passage (100-Y 0-N) — 99–0 (pass) · lower
- Constitutional reading dispensed (38-Y 1-N) — 38–1 (pass) · upper
- Reported from Health, Welfare and Institutions (22-Y 0-N) — 22–0 (pass) · lower
Sponsors
- Barbara A. Favola — primary (person)
- Kaye Kory — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-12-19 Prefiled and ordered printed; offered 01/12/22 22100296D
introduction - 2021-12-19 Referred to Committee on Education and Health
referral-committee - 2022-01-13 Senate committee, floor amendments and substitutes offered
- 2022-01-13 Reported from Education and Health with substitute (14-Y 0-N)
committee-passage - 2022-01-13 Committee substitute printed 22104388D-S1
substitution - 2022-01-14 Constitutional reading dispensed (38-Y 1-N)
- 2022-01-17 Read second time
reading-2 - 2022-01-17 Reading of substitute waived
- 2022-01-17 Committee substitute agreed to 22104388D-S1
- 2022-01-17 Engrossed by Senate - committee substitute SB14S1
- 2022-01-17 Impact statement from DPB (SB14S1)
- 2022-01-18 Read third time and passed Senate (40-Y 0-N)
passage, reading-3 - 2022-02-22 Placed on Calendar
- 2022-02-22 Read first time
reading-1 - 2022-02-22 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2022-02-24 Reported from Health, Welfare and Institutions (22-Y 0-N)
committee-passage - 2022-02-28 Read second time
reading-2 - 2022-03-01 Read third time
reading-3 - 2022-03-01 Passed House BLOCK VOTE (100-Y 0-N)
passage - 2022-03-01 VOTE: Block Vote Passage (100-Y 0-N)
- 2022-03-03 Enrolled
- 2022-03-03 Signed by Speaker
- 2022-03-04 Impact statement from DPB (SB14ER)
- 2022-03-04 Signed by President
- 2022-03-11 Enrolled Bill Communicated to Governor on March 11, 2022
- 2022-03-11 Governor's Action Deadline 11:59 p.m., April 11, 2022
- 2022-04-11 Governor's recommendation received by Senate
- 2022-04-27 Senate concurred in Governor's recommendation (40-Y 0-N)
- 2022-04-27 House concurred in Governor's recommendation BLOCK VOTE (100-Y 0-N)
- 2022-04-27 VOTE: Adoption (100-Y 0-N)
- 2022-04-27 Governor's recommendation adopted
- 2022-04-27 Reenrolled
- 2022-04-27 Reenrolled bill text (SB14ER2)
- 2022-04-27 Signed by President as reenrolled
- 2022-04-27 Signed by Speaker as reenrolled
- 2022-04-27 Enacted, Chapter 703 (effective 7/1/22)
became-law
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/42d8d282-3256-4fda-9a6c-44e774e0a099. Confidence: reported (aggregated from official Virginia legislature records).